KRAS and neoplasm: As shown in Fig. 1a, the most frequent variants occurred in APC (57.9% vs 19.7%), TP53 (55.3% vs 22.4%) and KRAS (47.4% vs 43.4%), both in tumor tissue and plasma ctDNA samples.